APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Diagnostic Reagent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Molecular Diagnostic Reagent Market Outlook and Growth Opportunities 2026

20 December 2025204 pages

Choose your research edition.

Industry ResearchMolecular Diagnostic Reagent Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Diagnostic Reagent Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Molecular Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Diagnostic Reagent Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Diagnostic Reagent Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Molecular Diagnostic Reagent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Molecular Diagnostic Reagent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Molecular Diagnostic Reagent market include Abbott Laboratories, Thermo Fisher Scientific, Merck KGaA, Roche Diagnostics, Siemens AG, Qiagen, Illumina, Hologic and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Molecular Diagnostic Reagent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Diagnostic Reagent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Diagnostic Reagent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Molecular Diagnostic Reagent market size, projected growth trends, production technologies, key applications, and end-use industries.

Molecular Diagnostic Reagent Segment by Company

Abbott Laboratories

Thermo Fisher Scientific

Merck KGaA

Roche Diagnostics

Siemens AG

Qiagen

Illumina

Hologic

Grifols

Diasorin

Danaher Corporation

DaAn Gene

Bio-Rad Laboratories

Biomérieux Sa

Becton, Dickinson and Company

Agilent Technologies

Molecular Diagnostic Reagent Segment by Type

Polymerase Chain Reaction PCR

Gene chip

Gene Sequencing

Molecular Hybridization

Molecular Diagnostic Reagent Segment by Application

Infectious Disease Diagnosis

Genetic Diagnosis

Blood Screening

Other

Molecular Diagnostic Reagent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Molecular Diagnostic Reagent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Molecular Diagnostic Reagent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Molecular Diagnostic Reagent significant trends, drivers, influence factors in global and regions.

6. To analyze Molecular Diagnostic Reagent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostic Reagent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Molecular Diagnostic Reagent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Diagnostic Reagent industry.

Chapter 3: Detailed analysis of Molecular Diagnostic Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Molecular Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Molecular Diagnostic Reagent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Molecular Diagnostic Reagent Industry Trends Table 2. Molecular Diagnostic Reagent Industry Drivers Table 3. Molecular Diagnostic Reagent Industry Opportunities and Challenges Table 4. Molecular Diagnostic Reagent Industry Restraints Table 5. Global Molecular Diagnostic Reagent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Molecular Diagnostic Reagent Revenue Share by Company (2021-2026) Table 7. Global Molecular Diagnostic Reagent Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Molecular Diagnostic Reagent Sales Volume Share by Company (2021-2026) Table 9. Global Molecular Diagnostic Reagent Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Molecular Diagnostic Reagent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Molecular Diagnostic Reagent Key Company Manufacturing Base & Headquarters Table 12. Global Molecular Diagnostic Reagent Company, Product Type & Application Table 13. Global Molecular Diagnostic Reagent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Molecular Diagnostic Reagent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Polymerase Chain Reaction PCR Table 18. Significant Companies of Gene chip Table 19. Significant Companies of Gene Sequencing Table 20. Significant Companies of Molecular Hybridization Table 21. Global Molecular Diagnostic Reagent Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Molecular Diagnostic Reagent Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Molecular Diagnostic Reagent Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Molecular Diagnostic Reagent Sales Volume Share by Type (2021-2026) Table 25. Global Molecular Diagnostic Reagent Sales Volume Share by Type (2027-2032) Table 26. Global Molecular Diagnostic Reagent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Molecular Diagnostic Reagent Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Molecular Diagnostic Reagent Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Molecular Diagnostic Reagent Sales Value Share by Type (2021-2026) Table 30. Global Molecular Diagnostic Reagent Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Infectious Disease Diagnosis Table 32. Significant Companies of Genetic Diagnosis Table 33. Significant Companies of Blood Screening Table 34. Significant Companies of Other Table 35. Global Molecular Diagnostic Reagent Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Molecular Diagnostic Reagent Sales Volume by Application (2021-2026) & (Tons) Table 37. Global Molecular Diagnostic Reagent Sales Volume by Application (2027-2032) & (Tons) Table 38. Global Molecular Diagnostic Reagent Sales Volume Share by Application (2021-2026) Table 39. Global Molecular Diagnostic Reagent Sales Volume Share by Application (2027-2032) Table 40. Global Molecular Diagnostic Reagent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Molecular Diagnostic Reagent Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Molecular Diagnostic Reagent Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Molecular Diagnostic Reagent Sales Value Share by Application (2021-2026) Table 44. Global Molecular Diagnostic Reagent Sales Value Share by Application (2027-2032) Table 45. Global Molecular Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 46. Global Molecular Diagnostic Reagent Sales by Region (2021-2026) & (Tons) Table 47. Global Molecular Diagnostic Reagent Sales Market Share by Region (2021-2026) Table 48. Global Molecular Diagnostic Reagent Sales by Region (2027-2032) & (Tons) Table 49. Global Molecular Diagnostic Reagent Sales Market Share by Region (2027-2032) Table 50. Global Molecular Diagnostic Reagent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Molecular Diagnostic Reagent Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Molecular Diagnostic Reagent Sales Value Share by Region (2021-2026) Table 53. Global Molecular Diagnostic Reagent Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Molecular Diagnostic Reagent Sales Value Share by Region (2027-2032) Table 55. Global Molecular Diagnostic Reagent Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Molecular Diagnostic Reagent Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Molecular Diagnostic Reagent Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. Global Molecular Diagnostic Reagent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Molecular Diagnostic Reagent Sales by Country (2021-2026) & (Tons) Table 60. Global Molecular Diagnostic Reagent Sales Market Share by Country (2021-2026) Table 61. Global Molecular Diagnostic Reagent Sales by Country (2027-2032) & (Tons) Table 62. Global Molecular Diagnostic Reagent Sales Market Share by Country (2027-2032) Table 63. Global Molecular Diagnostic Reagent Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Molecular Diagnostic Reagent Sales Value Market Share by Country (2021-2026) Table 65. Global Molecular Diagnostic Reagent Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Molecular Diagnostic Reagent Sales Value Market Share by Country (2027-2032) Table 67. Abbott Laboratories Company Information Table 68. Abbott Laboratories Business Overview Table 69. Abbott Laboratories Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Abbott Laboratories Molecular Diagnostic Reagent Product Portfolio Table 71. Abbott Laboratories Recent Development Table 72. Thermo Fisher Scientific Company Information Table 73. Thermo Fisher Scientific Business Overview Table 74. Thermo Fisher Scientific Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Thermo Fisher Scientific Molecular Diagnostic Reagent Product Portfolio Table 76. Thermo Fisher Scientific Recent Development Table 77. Merck KGaA Company Information Table 78. Merck KGaA Business Overview Table 79. Merck KGaA Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Merck KGaA Molecular Diagnostic Reagent Product Portfolio Table 81. Merck KGaA Recent Development Table 82. Roche Diagnostics Company Information Table 83. Roche Diagnostics Business Overview Table 84. Roche Diagnostics Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Roche Diagnostics Molecular Diagnostic Reagent Product Portfolio Table 86. Roche Diagnostics Recent Development Table 87. Siemens AG Company Information Table 88. Siemens AG Business Overview Table 89. Siemens AG Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Siemens AG Molecular Diagnostic Reagent Product Portfolio Table 91. Siemens AG Recent Development Table 92. Qiagen Company Information Table 93. Qiagen Business Overview Table 94. Qiagen Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Qiagen Molecular Diagnostic Reagent Product Portfolio Table 96. Qiagen Recent Development Table 97. Illumina Company Information Table 98. Illumina Business Overview Table 99. Illumina Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Illumina Molecular Diagnostic Reagent Product Portfolio Table 101. Illumina Recent Development Table 102. Hologic Company Information Table 103. Hologic Business Overview Table 104. Hologic Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Hologic Molecular Diagnostic Reagent Product Portfolio Table 106. Hologic Recent Development Table 107. Grifols Company Information Table 108. Grifols Business Overview Table 109. Grifols Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Grifols Molecular Diagnostic Reagent Product Portfolio Table 111. Grifols Recent Development Table 112. Diasorin Company Information Table 113. Diasorin Business Overview Table 114. Diasorin Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Diasorin Molecular Diagnostic Reagent Product Portfolio Table 116. Diasorin Recent Development Table 117. Danaher Corporation Company Information Table 118. Danaher Corporation Business Overview Table 119. Danaher Corporation Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Danaher Corporation Molecular Diagnostic Reagent Product Portfolio Table 121. Danaher Corporation Recent Development Table 122. DaAn Gene Company Information Table 123. DaAn Gene Business Overview Table 124. DaAn Gene Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. DaAn Gene Molecular Diagnostic Reagent Product Portfolio Table 126. DaAn Gene Recent Development Table 127. Bio-Rad Laboratories Company Information Table 128. Bio-Rad Laboratories Business Overview Table 129. Bio-Rad Laboratories Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. Bio-Rad Laboratories Molecular Diagnostic Reagent Product Portfolio Table 131. Bio-Rad Laboratories Recent Development Table 132. Biomérieux Sa Company Information Table 133. Biomérieux Sa Business Overview Table 134. Biomérieux Sa Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 135. Biomérieux Sa Molecular Diagnostic Reagent Product Portfolio Table 136. Biomérieux Sa Recent Development Table 137. Becton, Dickinson and Company Company Information Table 138. Becton, Dickinson and Company Business Overview Table 139. Becton, Dickinson and Company Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 140. Becton, Dickinson and Company Molecular Diagnostic Reagent Product Portfolio Table 141. Becton, Dickinson and Company Recent Development Table 142. Agilent Technologies Company Information Table 143. Agilent Technologies Business Overview Table 144. Agilent Technologies Molecular Diagnostic Reagent Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 145. Agilent Technologies Molecular Diagnostic Reagent Product Portfolio Table 146. Agilent Technologies Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Molecular Diagnostic Reagent Distributors List Table 150. Molecular Diagnostic Reagent Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Molecular Diagnostic Reagent Product Image Figure 2. Global Molecular Diagnostic Reagent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Molecular Diagnostic Reagent Sales (2021-2032) & (Tons) Figure 5. Global Molecular Diagnostic Reagent Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Molecular Diagnostic Reagent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Polymerase Chain Reaction PCR Image Figure 10. Gene chip Image Figure 11. Gene Sequencing Image Figure 12. Molecular Hybridization Image Figure 13. Global Molecular Diagnostic Reagent Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Molecular Diagnostic Reagent Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Molecular Diagnostic Reagent Sales Volume Share by Type (2021-2032) Figure 16. Global Molecular Diagnostic Reagent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Molecular Diagnostic Reagent Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Molecular Diagnostic Reagent Sales Value Share by Type (2021-2032) Figure 19. Infectious Disease Diagnosis Image Figure 20. Genetic Diagnosis Image Figure 21. Blood Screening Image Figure 22. Other Image Figure 23. Global Molecular Diagnostic Reagent Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Molecular Diagnostic Reagent Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Molecular Diagnostic Reagent Sales Volume Share by Application (2021-2032) Figure 26. Global Molecular Diagnostic Reagent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Molecular Diagnostic Reagent Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Molecular Diagnostic Reagent Sales Value Share by Application (2021-2032) Figure 29. Global Molecular Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 30. Global Molecular Diagnostic Reagent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Molecular Diagnostic Reagent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Molecular Diagnostic Reagent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Molecular Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 34. North America Molecular Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Molecular Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Molecular Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Molecular Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Molecular Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Molecular Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 40. South America Molecular Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Molecular Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Molecular Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Molecular Diagnostic Reagent Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Molecular Diagnostic Reagent Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Polymerase Chain Reaction PCR
  • Gene chip
  • Gene Sequencing
  • Molecular Hybridization
Applications
  • Infectious Disease Diagnosis
  • Genetic Diagnosis
  • Blood Screening
  • Other
Companies covered
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Merck KGaA
  • Roche Diagnostics
  • Siemens AG
  • Qiagen
  • Illumina
  • Hologic
  • Grifols
  • Diasorin
  • Danaher Corporation
  • DaAn Gene
  • Bio-Rad Laboratories
  • Biomérieux Sa
  • Becton, Dickinson and Company
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Molecular Diagnostic Reagent Sales Value (2021-2032)
  4. 1.2.2 Global Molecular Diagnostic Reagent Sales Volume (2021-2032)
  5. 1.2.3 Global Molecular Diagnostic Reagent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Molecular Diagnostic Reagent Market Dynamics
  1. 2.1 Molecular Diagnostic Reagent Industry Trends
  2. 2.2 Molecular Diagnostic Reagent Industry Drivers
  3. 2.3 Molecular Diagnostic Reagent Industry Opportunities and Challenges
  4. 2.4 Molecular Diagnostic Reagent Industry Restraints
3 Molecular Diagnostic Reagent Market by Company
  1. 3.1 Global Molecular Diagnostic Reagent Company Revenue Ranking in 2025
  2. 3.2 Global Molecular Diagnostic Reagent Revenue by Company (2021-2026)
  3. 3.3 Global Molecular Diagnostic Reagent Sales Volume by Company (2021-2026)
  4. 3.4 Global Molecular Diagnostic Reagent Average Price by Company (2021-2026)
  5. 3.5 Global Molecular Diagnostic Reagent Company Ranking (2024-2026)
  6. 3.6 Global Molecular Diagnostic Reagent Company Manufacturing Base and Headquarters
  7. 3.7 Global Molecular Diagnostic Reagent Company Product Type and Application
  8. 3.8 Global Molecular Diagnostic Reagent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Molecular Diagnostic Reagent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Molecular Diagnostic Reagent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Molecular Diagnostic Reagent Market by Type
  1. 4.1 Molecular Diagnostic Reagent Type Introduction
  2. 4.1.1 Polymerase Chain Reaction PCR
  3. 4.1.2 Gene chip
  4. 4.1.3 Gene Sequencing
  5. 4.1.4 Molecular Hybridization
  6. 4.2 Global Molecular Diagnostic Reagent Sales Volume by Type
  7. 4.2.1 Global Molecular Diagnostic Reagent Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Molecular Diagnostic Reagent Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Molecular Diagnostic Reagent Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Molecular Diagnostic Reagent Sales Value by Type
  11. 4.3.1 Global Molecular Diagnostic Reagent Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Molecular Diagnostic Reagent Sales Value by Type (2021-2032)
  13. 4.3.3 Global Molecular Diagnostic Reagent Sales Value Share by Type (2021-2032)
5 Molecular Diagnostic Reagent Market by Application
  1. 5.1 Molecular Diagnostic Reagent Application Introduction
  2. 5.1.1 Infectious Disease Diagnosis
  3. 5.1.2 Genetic Diagnosis
  4. 5.1.3 Blood Screening
  5. 5.1.4 Other
  6. 5.2 Global Molecular Diagnostic Reagent Sales Volume by Application
  7. 5.2.1 Global Molecular Diagnostic Reagent Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Molecular Diagnostic Reagent Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Molecular Diagnostic Reagent Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Molecular Diagnostic Reagent Sales Value by Application
  11. 5.3.1 Global Molecular Diagnostic Reagent Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Molecular Diagnostic Reagent Sales Value by Application (2021-2032)
  13. 5.3.3 Global Molecular Diagnostic Reagent Sales Value Share by Application (2021-2032)
6 Molecular Diagnostic Reagent Regional Sales and Value Analysis
  1. 6.1 Global Molecular Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Diagnostic Reagent Sales by Region (2021-2032)
  3. 6.2.1 Global Molecular Diagnostic Reagent Sales by Region: 2021-2026
  4. 6.2.2 Global Molecular Diagnostic Reagent Sales by Region (2027-2032)
  5. 6.3 Global Molecular Diagnostic Reagent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Molecular Diagnostic Reagent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Molecular Diagnostic Reagent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Molecular Diagnostic Reagent Sales Value by Region (2027-2032)
  9. 6.5 Global Molecular Diagnostic Reagent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Molecular Diagnostic Reagent Sales Value (2021-2032)
  12. 6.6.2 North America Molecular Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Molecular Diagnostic Reagent Sales Value (2021-2032)
  15. 6.7.2 Europe Molecular Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Molecular Diagnostic Reagent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Molecular Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Molecular Diagnostic Reagent Sales Value (2021-2032)
  21. 6.9.2 South America Molecular Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Molecular Diagnostic Reagent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Molecular Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
7 Molecular Diagnostic Reagent Country-level Sales and Value Analysis
  1. 7.1 Global Molecular Diagnostic Reagent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Molecular Diagnostic Reagent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Molecular Diagnostic Reagent Sales by Country (2021-2032)
  4. 7.3.1 Global Molecular Diagnostic Reagent Sales by Country (2021-2026)
  5. 7.3.2 Global Molecular Diagnostic Reagent Sales by Country (2027-2032)
  6. 7.4 Global Molecular Diagnostic Reagent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Molecular Diagnostic Reagent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Molecular Diagnostic Reagent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Molecular Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Molecular Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Molecular Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Molecular Diagnostic Reagent Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Molecular Diagnostic Reagent Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Molecular Diagnostic Reagent Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 Roche Diagnostics
  20. 8.4.1 Roche Diagnostics Company Information
  21. 8.4.2 Roche Diagnostics Business Overview
  22. 8.4.3 Roche Diagnostics Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche Diagnostics Molecular Diagnostic Reagent Product Portfolio
  24. 8.4.5 Roche Diagnostics Recent Developments
  25. 8.5 Siemens AG
  26. 8.5.1 Siemens AG Company Information
  27. 8.5.2 Siemens AG Business Overview
  28. 8.5.3 Siemens AG Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Siemens AG Molecular Diagnostic Reagent Product Portfolio
  30. 8.5.5 Siemens AG Recent Developments
  31. 8.6 Qiagen
  32. 8.6.1 Qiagen Company Information
  33. 8.6.2 Qiagen Business Overview
  34. 8.6.3 Qiagen Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Qiagen Molecular Diagnostic Reagent Product Portfolio
  36. 8.6.5 Qiagen Recent Developments
  37. 8.7 Illumina
  38. 8.7.1 Illumina Company Information
  39. 8.7.2 Illumina Business Overview
  40. 8.7.3 Illumina Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Illumina Molecular Diagnostic Reagent Product Portfolio
  42. 8.7.5 Illumina Recent Developments
  43. 8.8 Hologic
  44. 8.8.1 Hologic Company Information
  45. 8.8.2 Hologic Business Overview
  46. 8.8.3 Hologic Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hologic Molecular Diagnostic Reagent Product Portfolio
  48. 8.8.5 Hologic Recent Developments
  49. 8.9 Grifols
  50. 8.9.1 Grifols Company Information
  51. 8.9.2 Grifols Business Overview
  52. 8.9.3 Grifols Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Grifols Molecular Diagnostic Reagent Product Portfolio
  54. 8.9.5 Grifols Recent Developments
  55. 8.10 Diasorin
  56. 8.10.1 Diasorin Company Information
  57. 8.10.2 Diasorin Business Overview
  58. 8.10.3 Diasorin Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Diasorin Molecular Diagnostic Reagent Product Portfolio
  60. 8.10.5 Diasorin Recent Developments
  61. 8.11 Danaher Corporation
  62. 8.11.1 Danaher Corporation Company Information
  63. 8.11.2 Danaher Corporation Business Overview
  64. 8.11.3 Danaher Corporation Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Danaher Corporation Molecular Diagnostic Reagent Product Portfolio
  66. 8.11.5 Danaher Corporation Recent Developments
  67. 8.12 DaAn Gene
  68. 8.12.1 DaAn Gene Company Information
  69. 8.12.2 DaAn Gene Business Overview
  70. 8.12.3 DaAn Gene Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 DaAn Gene Molecular Diagnostic Reagent Product Portfolio
  72. 8.12.5 DaAn Gene Recent Developments
  73. 8.13 Bio-Rad Laboratories
  74. 8.13.1 Bio-Rad Laboratories Company Information
  75. 8.13.2 Bio-Rad Laboratories Business Overview
  76. 8.13.3 Bio-Rad Laboratories Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bio-Rad Laboratories Molecular Diagnostic Reagent Product Portfolio
  78. 8.13.5 Bio-Rad Laboratories Recent Developments
  79. 8.14 Biomérieux Sa
  80. 8.14.1 Biomérieux Sa Company Information
  81. 8.14.2 Biomérieux Sa Business Overview
  82. 8.14.3 Biomérieux Sa Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Biomérieux Sa Molecular Diagnostic Reagent Product Portfolio
  84. 8.14.5 Biomérieux Sa Recent Developments
  85. 8.15 Becton, Dickinson and Company
  86. 8.15.1 Becton, Dickinson and Company Company Information
  87. 8.15.2 Becton, Dickinson and Company Business Overview
  88. 8.15.3 Becton, Dickinson and Company Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Becton, Dickinson and Company Molecular Diagnostic Reagent Product Portfolio
  90. 8.15.5 Becton, Dickinson and Company Recent Developments
  91. 8.16 Agilent Technologies
  92. 8.16.1 Agilent Technologies Company Information
  93. 8.16.2 Agilent Technologies Business Overview
  94. 8.16.3 Agilent Technologies Molecular Diagnostic Reagent Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Agilent Technologies Molecular Diagnostic Reagent Product Portfolio
  96. 8.16.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Molecular Diagnostic Reagent Value Chain Analysis
  2. 9.1.1 Molecular Diagnostic Reagent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Molecular Diagnostic Reagent Sales Mode & Process
  6. 9.2 Molecular Diagnostic Reagent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Molecular Diagnostic Reagent Distributors
  9. 9.2.3 Molecular Diagnostic Reagent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst